Medicines With The Active Ingredient Combination Vilanterol, Umeclidinium Bromide And Fluticasone Furoate (Atc: R03Al08)

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 81139917

  Document Type - Tender Notices

Description - Description: The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130c Paragraph 1 SGB V in conjunction with Section 130a Paragraph 8 SGB V for finished medicinal products with the active i ngredient combination vilanterol, umeclidinium bromide and fluticasone furoate (ATC: R03AL08) within the framework of a so-called "open-house" model". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are required to conclude or join a discount agreement in accordance with Section 130c Paragraph 1 SGB V in conjunction with Secti

Gt Ref Id - 81139917

Deadline - Mar 31, 2026